HealthQuill Antitrust law
Antitrust regulators in the UK have cleared a $3.1 billion acquisition of Olink Holding AB by Thermo Fisher Scientific Inc., following an initial probe that began in May last year.
Drugs Medical Pharma

Thermo Fisher’s $3.1 billion buy of Olink gets UK competition regulators’ nod

Antitrust regulators in the UK have cleared a $3.1 billion acquisition of Olink Holding AB by Thermo Fisher Scientific Inc., following an initial.

Read More
Dr. Reddy's Meloma Patent antitrust law
Drugs Pharma

US court dismisses antitrust claims against Dr. Reddy’s cancer drug

A US court dismissed all claims against Dr. Reddy's Laboratories Inc., a wholly-owned subsidiary, in an antitrust complaint related to the cancer drug.

Read More